The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy and safety of weekly oral vinorelbine (NVBO) as single agent in first- or second-line metastatic breast cancer (MBC).
Serafin Morales
No relevant relationships to disclose
Isabel Blancas
No relevant relationships to disclose
Maria Luisa Gonzalvez
No relevant relationships to disclose
Agust Barnadas
No relevant relationships to disclose
Nieves Diaz
No relevant relationships to disclose
Sonia Servitja
No relevant relationships to disclose
Sonia del Barco
No relevant relationships to disclose
Mireia Margeli
No relevant relationships to disclose
Iciar Garcia Carbonero
No relevant relationships to disclose
Ruth Alvarez
No relevant relationships to disclose
Maria Helena Lopez de Ceballos
No relevant relationships to disclose
Francisco Javier Perez
No relevant relationships to disclose
Antonio Llombart Cussac
No relevant relationships to disclose